News & Updates

Fewer migraine days with zonisamide in children

11 Jun 2025 by

A retrospective cohort study presented at AAN 2025 has demonstrated that prophylactic zonisamide can significantly reduce headache days per month (HDPM) in paediatric patients with migraine.

Fewer migraine days with zonisamide in children

11 Jun 2025

V-ERAT trumps antibiotics for uncomplicated acute appendicitis

10 Jun 2025

Patients with uncomplicated acute appendicitis may opt for visual endoscopic retrograde appendicitis therapy (V-ERAT) as a safe and effective alternative to antibiotic treatment to reduce the risk of recurrence, according to a study.

V-ERAT trumps antibiotics for uncomplicated acute appendicitis

10 Jun 2025

Is social media a reliable source of paediatric drug information?

10 Jun 2025 by

Using social media to obtain relevant information is possible, with a recent study suggesting that data from child-rearing public parenting forums (CPPFs) may aid in assessing paediatric adverse drug events and in detecting unknown adverse drug reactions (ADRs) and medication errors.

Is social media a reliable source of paediatric drug information?

10 Jun 2025

Are statins protective against HCC?

10 Jun 2025 by

In a study presented at EASL 2025, the use of statins appears to be associated with a reduced risk of hepatocellular carcinoma (HCC) and slower progression of liver fibrosis in individuals with chronic liver disease (CLD).

Are statins protective against HCC?

10 Jun 2025

Efruxifermin misses mark in MASH-related compensated cirrhosis

10 Jun 2025

Treatment with the bivalent fibroblast growth factor 21 (FGF21) analogue efruxifermin falls short of improving fibrosis in patients with compensated cirrhosis caused by metabolic dysfunction–associated steatohepatitis (MASH), according to a phase 2b study.